纳米载体
脂质体
内生
癌症治疗
癌症
医学
药理学
纳米技术
内科学
材料科学
药品
作者
Jazmín Torres,Johanna Karina Valenzuela Oses,Antonio María Rabasco,María Luisa González-Rodríguez,Mónica Cristina García
出处
期刊:Pharmaceutics
[Multidisciplinary Digital Publishing Institute]
日期:2025-02-13
卷期号:17 (2): 245-245
被引量:60
标识
DOI:10.3390/pharmaceutics17020245
摘要
Recent advancements in nanotechnology have revolutionized cancer therapy-one of the most pressing global health challenges and a leading cause of death-through the development of liposomes (L), lipid-based nanovesicles known for their biocompatibility and ability to encapsulate both hydrophilic and lipophilic drugs. More recent innovations have led to the creation of stimuli-responsive L that release their payloads in response to specific endogenous or exogenous triggers. Dual- and multi-responsive L, which react to multiple stimuli, offer even greater precision, improving therapeutic outcomes while reducing systemic toxicity. Additionally, these smart L can adjust their physicochemical properties and morphology to enable site-specific targeting and controlled drug release, enhancing treatment efficacy while minimizing adverse effects. This review explores the latest advancements in endogenous stimuli-responsive liposomal nanocarriers, as well as dual- and multi-responsive L that integrate internal and external triggers, with a focus on their design strategies, mechanisms, and applications in cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI